Hologic, Inc. reported impairment of intangible assets for the second quarter ended March 30, 2024. For the quarter, the company reported impairment of intangible assets of $26.8 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
75.02 USD | +0.09% | -0.16% | +5.00% |
05-09 | Argus Adjusts Price Target on Hologic to $95 From $89 | MT |
05-06 | Lumos Diagnostics Concludes Initial Phase of Development Deal with Hologic for Fetal Fibronectin Test; Shares Jump 6% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.00% | 17.49B | |
+12.15% | 228B | |
+14.90% | 196B | |
+18.22% | 141B | |
+29.15% | 110B | |
+0.53% | 65.88B | |
+16.92% | 54.3B | |
+6.33% | 52.39B | |
+10.93% | 45.22B | |
+5.87% | 37.12B |
- Stock Market
- Equities
- HOLX Stock
- News Hologic, Inc.
- Hologic, Inc. Reports Impairment of Intangible Assets for the Second Quarter Ended March 30, 2024